Measuring disease activity in COPD: is clinically important deterioration the answer?

Given the heterogeneity of chronic obstructive pulmonary disease (COPD), personalized clinical management is key to optimizing patient outcomes. Important treatment goals include minimizing disease activity and preventing disease progression; however, quantification of these components remains a cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Criner, Gerard J., Naya, Ian, Jones, Paul W., Tombs, Lee, Lipson, David A., Han, MeiLan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265253/
https://www.ncbi.nlm.nih.gov/pubmed/32487202
http://dx.doi.org/10.1186/s12931-020-01387-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265253/
https://www.ncbi.nlm.nih.gov/pubmed/32487202
http://dx.doi.org/10.1186/s12931-020-01387-z

Ejemplares similares